Dataset from A Phase I/II Randomized, Double-blind, Placebo-controlled Multicentre Study in Participants Aged 18 Years or Older to Determine the Safety and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, for the Prevention of COVID-19
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00008580
下载链接
链接失效反馈官方服务：
资源简介：
The COVID-19 pandemic has caused major disruption to healthcare systems with significant
socioeconomic impacts. Currently, there are no licensed preventions available against
COVID-19 and accelerated vaccine development is urgently needed. A safe and effective vaccine
for COVID 19 prevention would have significant global public health impact.
创建时间：
2024-11-27
